CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk

被引：0
|
作者：
Sohee Han
Kyoung-Mu Lee
Ji-Yeob Choi
Sue Kyung Park
Ji-Young Lee
Jong Eun Lee
Dong-Young Noh
Sei-Hyun Ahn
Wonshik Han
Dong-Hyun Kim
Yun-Chul Hong
Eunhee Ha
Keun-Young Yoo
Daehee Kang
机构：
[1] Seoul National University College of Medicine,Department of Preventive Medicine
[2] National Cancer Institute,Division of Cancer Epidemiology and Genetics
[3] Roswell Park Cancer Institute,Department of Epidemiology
[4] DNA Link Inc.,Department of Surgery
[5] Seoul National University College of Medicine,Department of Surgery
[6] Ulsan University College of Medicine,Department of Social and Preventive Medicine
[7] Hallym University College of Medicine,Department of Preventive Medicine
[8] Ewha Womans University,Cancer Research Institute
[9] Korea National Cancer Center,undefined
[10] Seoul National University,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 110卷
关键词：
Breast cancer; Estrogen receptor; Polymorphism; Progesterone receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 393
页数：6
相关论文
共 50 条
  • [21] Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis
    Hashemi, Mohammad
    Aftabi, Sajjad
    Moazeni-Roodi, Abdolkarim
    Sarani, Hosna
    Wiechec, Emilia
    Ghavami, Saeid
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 881
  • [22] Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status
    Rusiecki J.A.
    Holford T.R.
    Zahm S.H.
    Zheng T.
    [J]. European Journal of Epidemiology, 2004, 19 (8) : 793 - 801
  • [23] Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
    Zhang, Min
    Yang, Hongjian
    Holman, C. D'Arcy J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (03) : 553 - 563
  • [24] Discordant Estrogen and Progesterone Receptor Status in Breast Cancer
    Hefti, M. M.
    Hu, R.
    Knoblauch, N.
    Collins, L.
    Tamimi, R. M.
    Beck, A. H.
    [J]. CANCER RESEARCH, 2012, 72
  • [25] Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
    Min Zhang
    Hongjian Yang
    C. D’Arcy J. Holman
    [J]. Breast Cancer Research and Treatment, 2009, 118 : 553 - 563
  • [26] Differences in breast cancer risk factors by estrogen and progesterone receptor status.
    Byrne, C
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 131 - 131
  • [27] Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status
    Rusiecki, JA
    Holford, TR
    Zahm, SH
    Zheng, TZ
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (08) : 793 - 801
  • [28] A promoter polymorphism in the CASP8 gene is not associated with cancer risk
    Christopher A Haiman
    Rachel R Garcia
    Laurence N Kolonel
    Brian E Henderson
    Anna H Wu
    Loïc Le Marchand
    [J]. Nature Genetics, 2008, 40 : 259 - 260
  • [29] A promoter polymorphism in the CASP8 gene is not associated with cancer risk
    Haiman, Christopher A.
    Garcia, Rachel R.
    Kolonel, Laurence N.
    Henderson, Brian E.
    Wu, Anna H.
    Le Marchand, Loic
    [J]. NATURE GENETICS, 2008, 40 (03) : 259 - 260
  • [30] Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk
    Vang, Alecia
    Salem, Kelley
    Fowler, Amy M.
    [J]. ENDOCRINOLOGY, 2023, 164 (04)
12345